secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001213900-24-081023
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Charles R. Carter to depart CERo Therapeutics; successor search underway
----------------------------------------------------------------------------

- CFO Charles R. Carter informed Board he will leave on Sept 30, 2024 for a role at another public company.
- Board has commenced a search for a new CFO; Carter will assist with transition for a brief period.
- Carter's departure is effective Sept 30, 2024; no successor named yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/0001213900-24-081023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/ea021534602-8k_cerothera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-081023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer